Bioequivalence of Acer Capsule to Airtal Tablet (Aceclofenac 100 mg)

에어탈 정(아세클로페낙 100 mg)에 대한 에이서 캅셀의 생물학적 동등성

  • Cho, Hea Young (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
  • Kim, Soo Jin (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
  • Oh, In Joon (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
  • Moon, Jai Dong (Medical School, Chonnam National University) ;
  • Lee, Yong Bok (College of Pharmacy and Research Institute of Drug Development, Chonnam National University)
  • 조혜영 (전남대학교 약학대학/약품개발연구소) ;
  • 김수진 (전남대학교 약학대학/약품개발연구소) ;
  • 오인준 (전남대학교 약학대학/약품개발연구소) ;
  • 문재동 (전남대학교 의과대학) ;
  • 이용복 (전남대학교 약학대학/약품개발연구소)
  • Published : 2002.03.01

Abstract

Aceclofenac, 2-[(2',6'-dichlorphenyl)amino]phenylacetoxiacetic acid, is a new nonsteroidal anti-inflammatory drug that belongs to the family of phenylacetic acids. It shows good tolerance and potent analgesic/antiinflammatory properties, and acts on cartilaginous chondriocytes, stimulating their repair mechanism. The purpose of the present study was to evaluate the bioequivalence of two aceclofenac products, $Airtal^{TM}$ tablet (Daewoong Pharmaceutical Co.) and $Acer^{TM}$ capsule (Kyungdong Pharmaceutical Co.), according to the guideliner of Korea Food and Drug Administration (KFDA). The aceclofenac release from the two aceclofenac products in vitro was tested using KP VII Apparatus II method at pH 7.8 dissolution media. Sixteen normal male volunteers, $23.13\pm2.03$ years in age and $66.33\pm7.08$ kg in body weight, were divided into two groups and a randomized $2\times2$ cross-over study was employed. After one tablet or capsule containing 100 mg of aceclofenac was orally administered, blood was taken at predetermined time intervals and the concentrations of aceclofenac in serum were determined using HPLC with UV detector. The dissolution profiles of the two aceclofenac products were very similar at pH 7.8 dissolution media. The pharmacokinetic parameters such as $AUC_t,\;C_{max}\;and\;T_max$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters. The results showed that the differences in $AUC_t,\;C_{max}\;and\;T_{max}$ between two products were $6.50\%,\;-1.06\%\;and\;11.96\%$ respectively, when calculated against the $Airtal^{TM}$ tablet. The powers $(1-\beta)\;for\;AUC_t,\;C_{max}\;were\;89.82\%\;and\;82.84\%$, respectively. Minimum detectable differences $(\Delta)\;at\;\alpha=0.05\;and\;1-\beta=0.8$ were less than $20\%\;(e.g.,\;17.51\%\;and\;19.30\%\;for\;AUC_t,\;C_{max}$, ). The $90\%$ confidence intervals were within $\pm20\%\;(e.g.,\;-3.73\%\sim16.73\%\;and\;-12.34\%\sim10.22\%\;for\;AUC_t,\;C_{max},\;respectively)$. Two parameters met the criteria of KFDA for bioequivalence, indicating that $Acer^{TM}$ capsule is bioequivalent to $Airtal^{TM}$ tablet.

Keywords